In sixteen pages this paper provides a financial assessment of Dr. Reddy's and compares it with Takeda Chemical Industries, GlaxoSmithKline, and Aventis and also provides a performance evaluation as well as a Porter's Five Forces model analysis. Twenty one sources are cited in the bibliography and there are also the inclusion of three tables.
Name of Research Paper File: MM12_PGreddy.msw
Unformatted Sample Text from the Research Paper:
paper presents an analysis of this company and provides a financial comparison between Dr. Reddys, Aventis, GlaxoSmithKline and Takeda Chemical Industries. Headings include an introduction that offers a brief background
of the company; company strategy, competitor analysis, industry analysis, and performance analysis of the four companies. Porters five force analysis is used. 3 tables/illustrations are included. Bibliography lists 21 sources.
PGreddy.msw DR. REDDYS LABORATORIES LIMITED , August, 2001 properly! [Note to student: As our
office explained, it was impossible to include everything in this size paper as you requested. To even have touched on every topic would have resulted in a choppy paper making
little sense in sections. A business analysis such as you requested is usually give at least 22 pages and often a great deal more. I have included as much of
your request as possible.] Introduction Founded in 1984 by Dr. K. Anji Reddy, Dr. Reddys Laboratories Limited, one of the major drug-makers in India, develops and produces generic pharmaceuticals,
branded pharmaceuticals and bulk ingredients for pharmaceuticals. Products include medicines for ulcers, such as Omez and Zovanta, pain relievers, cardiovascular drugs and antibiotics. The company also manufactures about four dozen
diagnostic-type products, such as those used as pregnancy tests. Further, Dr. Reddys Laboratories is very involved in the biotech business (Hoovers, 2001). The company lists its activities as "Bulk Actives
& Pharmaceutical Intermediates, Finished Dosage Forms, Diagnostics, Drug Discovery, Generics, Biotechnology, Critical Care, Custom Chemical Services" (Dr. Reddys Laboratories, 2001). The company has a presence in more than 65
countries and is involved in numerous joint ventures and other kinds of joint agreements, such as their marketing agreement with Watson Pharmaceuticals in the United States. Even with such a